These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25768103)

  • 41. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis.
    Ito T; Igarashi H; Nakamura K; Sasano H; Okusaka T; Takano K; Komoto I; Tanaka M; Imamura M; Jensen RT; Takayanagi R; Shimatsu A
    J Gastroenterol; 2015 Jan; 50(1):58-64. PubMed ID: 24499825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinicopathologic characteristics of 127 cases of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) studied in an oncology hospital].
    Alvarado-Cabrero I; de Anda-González J; Hernández-Hernández B; Mantilla-Morales A; Valencia-Cedillo R; Medrano-Guzmán R
    Rev Gastroenterol Mex; 2012; 77(4):174-80. PubMed ID: 23142406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The ENETS and UICC TNM classification of neuroendocrine tumors of the gastrointestinal tract and the pancreas: comment].
    Klöppel G; Rindi G; Perren A; Komminoth P; Klimstra DS
    Pathologe; 2010 Sep; 31(5):353-4. PubMed ID: 20809402
    [No Abstract]   [Full Text] [Related]  

  • 44. Role of endoscopy in the management of gastroenteropancreatic neuroendocrine tumours.
    De Angelis C; Pellicano R; Rizzetto M; Repici A
    Minerva Gastroenterol Dietol; 2011 Jun; 57(2):129-37. PubMed ID: 21587152
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Standardization in pathologic diagnosis of gastrointestinal and pancreatic neuroendocrine tumors].
    Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):793-5. PubMed ID: 21215092
    [No Abstract]   [Full Text] [Related]  

  • 46. [Neuroendocrine tumors of the gastroenteropancreatic system--reevaluation using the Capella classification].
    Brüwer M; Pahlov-Nejad T; Herbst H; Senninger N; Schürmann G
    Zentralbl Chir; 2003 Aug; 128(8):656-62. PubMed ID: 12931261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surgery for gastroenteropancreatic neuroendocrine tumors (GEPNETS).
    Boudreaux JP
    Endocrinol Metab Clin North Am; 2011 Mar; 40(1):163-71, ix. PubMed ID: 21349417
    [TBL] [Abstract][Full Text] [Related]  

  • 48. mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours.
    Kasajima A; Pavel M; Darb-Esfahani S; Noske A; Stenzinger A; Sasano H; Dietel M; Denkert C; Röcken C; Wiedenmann B; Weichert W
    Endocr Relat Cancer; 2011 Feb; 18(1):181-92. PubMed ID: 21159731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors.
    Asa SL; La Rosa S; Basturk O; Adsay V; Minnetti M; Grossman AB
    Endocr Pathol; 2021 Mar; 32(1):169-191. PubMed ID: 33459926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The confusion around neuroendocrine tumors.
    Hendlisz A; Deleporte A
    Curr Opin Oncol; 2012 Jul; 24(4):431-2. PubMed ID: 22476192
    [No Abstract]   [Full Text] [Related]  

  • 51. The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement.
    Klöppel G; Rindi G; Perren A; Komminoth P; Klimstra DS
    Virchows Arch; 2010 Jun; 456(6):595-7. PubMed ID: 20422210
    [No Abstract]   [Full Text] [Related]  

  • 52. Biomarkers and molecular imaging in gastroenteropancreatic neuroendocrine tumors.
    Lindholm DP; Oberg K
    Horm Metab Res; 2011 Nov; 43(12):832-7. PubMed ID: 22009449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An overview of the current diagnosis and recent developments in neuroendocrine tumours of the gastroenteropancreatic tract: the diagnostic approach.
    Kuiper P; Verspaget HW; Overbeek LI; Biemond I; Lamers CB
    Neth J Med; 2011 Jan; 69(1):14-20. PubMed ID: 21325696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors.
    Lubomierski N; Kersting M; Bert T; Muench K; Wulbrand U; Schuermann M; Bartsch D; Simon B
    Cancer Res; 2001 Aug; 61(15):5905-10. PubMed ID: 11479232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and efficacy of everolimus in gastrointestinal and pancreatic neuroendocrine tumors after (177)Lu-octreotate.
    Kamp K; Gumz B; Feelders RA; Kwekkeboom DJ; Kaltsas G; Costa FP; de Herder WW
    Endocr Relat Cancer; 2013 Dec; 20(6):825-31. PubMed ID: 24036133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
    Starker LF; Carling T
    Curr Opin Oncol; 2009 Jan; 21(1):29-33. PubMed ID: 19125015
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of somatostatin receptor subtype expression in human neuroendocrine tumors using two sets of new monoclonal antibodies.
    Lambertini C; Barzaghi-Rinaudo P; D'Amato L; Schulz S; Nuciforo P; Schmid HA
    Regul Pept; 2013 Nov; 187():35-41. PubMed ID: 24188818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors.
    Strosberg J; Nasir A; Coppola D; Wick M; Kvols L
    Hum Pathol; 2009 Sep; 40(9):1262-8. PubMed ID: 19368957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
    Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U
    Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part II-specific NE tumour types.
    Oberg K; Astrup L; Eriksson B; Falkmer SE; Falkmer UG; Gustafsen J; Haglund C; Knigge U; Vatn MH; Välimäki M;
    Acta Oncol; 2004; 43(7):626-36. PubMed ID: 15545183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.